An 11-year experience of carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa bacteremia

被引：0
|
作者：
Cho, E. [1 ]
Choi, S. -H. [1 ]
Chung, J. -W. [1 ]
机构：
[1] Chung Ang Univ Hosp, Dept Internal Med, Div Infect Dis, Seoul, South Korea
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2017年 / 50卷
关键词：
Acinetobacter baumannii; Pseudomonas aeruginosa; carbapenem; resistance;
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
P1-GN13
引用
收藏
页码：S98 / S98
页数：1
相关论文
共 50 条
  • [1] Associations between Carbapenem Use, Carbapenem-Resistant Pseudomonas aeruginosa, and Carbapenem-Resistant Acinetobacter baumannii
    Apisarnthanarak, Anucha
    Jitpokasem, Sumana
    Mundy, Linda M.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2013, 34 (11): : 1235 - 1237
  • [2] Carbapenem-resistant Acinetobacter baumannii Bacteremia in Neonates
    Nakwan, Narongsak
    Chokephaibulkit, Kulkanya
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (02) : 197 - 197
  • [3] Epidemiology and outcomes associated with carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study
    Vivo, Amanda
    Fitzpatrick, Margaret A.
    Suda, Katie J.
    Jones, Makoto M.
    Perencevich, Eli N.
    Rubin, Michael A.
    Ramanathan, Swetha
    Wilson, Geneva M.
    Evans, Martin E.
    Evans, Charlesnika T.
    [J]. BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [4] Epidemiology and outcomes associated with carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study
    Amanda Vivo
    Margaret A. Fitzpatrick
    Katie J. Suda
    Makoto M. Jones
    Eli N. Perencevich
    Michael A. Rubin
    Swetha Ramanathan
    Geneva M. Wilson
    Martin E. Evans
    Charlesnika T. Evans
    [J]. BMC Infectious Diseases, 22
  • [5] Carbapenem-resistant Pseudomonas and Acinetobacter
    Kamarulzaman, A.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E38 - E38
  • [6] The Rise of Carbapenem-Resistant Acinetobacter baumannii
    Evans, Benjamin A.
    Hamouda, Ahmed
    Amyes, Sebastian G. B.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (02) : 223 - 238
  • [7] Carbapenem-Resistant Pseudomonas aeruginosa
    Eraksoy, Haluk
    [J]. KLIMIK JOURNAL, 2014, 27 (02) : 37 - 37
  • [8] Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia
    Garnacho-Montero, Jose
    Amaya-Villar, Rosario
    Ferrandiz-Millon, Carmen
    Diaz-Martin, Ana
    Maria Lopez-Sanchez, Jose
    Gutierrez-Pizarraya, Antonio
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2015, 13 (06) : 769 - 777
  • [9] Carbapenem-resistant Acinetobacter baumannii Bacteremia in Liver Transplant Recipients
    Kim, Y. J.
    Kim, S. I.
    Lee, Y. D.
    Choi, H. J.
    Choi, J. Y.
    Yoon, S. K.
    You, Y-K.
    Kim, D. -G.
    [J]. TRANSPLANTATION PROCEEDINGS, 2018, 50 (04) : 1132 - 1135
  • [10] Bulgecin A as a β-lactam enhancer for carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii clinical isolates containing various resistance mechanisms
    Skalweit, Marion J.
    Li, Mei
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 3013 - 3020
12345